ENTRELAC.COOP
Entrelac.coop is a French cooperative (SCIC) founded in 2022 in Bordeaux that incubates and funds the certification of male contraception medical devices, led by its flagship thermal contraception ring project targeting European pharmacy availability by 2028.
- Company typePrivate
- Founded2022
- HeadquartersBordeaux, France
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What ENTRELAC.COOP does
Entrelac.coop is a French cooperative company (Société Coopérative d'Intérêt Collectif, SCIC) founded in 2022 and headquartered in Bordeaux, positioning itself as the first cooperative in Europe dedicated to innovation in male contraception. Its primary mission is to support project leaders in the certification and market launch of male contraception medical devices, with the flagship project being the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique) — a reversible heat-based device targeting effectiveness comparable to vasectomy or hormonal implants, with planned availability in European pharmacies by 2028. The company also publishes a Practical Guide to Thermal Contraception, which won the UNESCO Chair Sexual Health & Human Rights First Innovation Prize in 2023.
The core technology is a non-hormonal, heat-based contraceptive ring worn by the user; effectiveness claims rest on three-month spermogram data from named user testimonials rather than published clinical trial endpoints in the disclosed sources. The business model is community-driven rather than venture-backed: members purchase social shares at a fixed 50€ per share (with no market fluctuation and an 18% Madelin-law tax deduction through end-2023), supplemented by one-time and recurring donations. Distribution is entirely direct-to-individual via the societaire.entrelac.coop portal, and the company discloses 0 sociétaires and 52% achievement of its funding target at the most recent scrape.
Strategic positioning is supported by a small set of recognitions — the 2022 Male Contraception Initiative Development Award for clinical trial funding, the 2023 UNESCO Innovation Prize, and a 2023 Région Nouvelle-Aquitaine cooperative-creation grant — and by earned media placements across France Info, Médiapart, France 5, Envoyé Spécial, and Neon Magazine. There is no institutional venture capital, no M&A activity, no patents disclosed, no AI/ML capability disclosed, and the management team is led by Antoine Kolodziej as Director of Publication, with the only formal external partnership being a visual-identity engagement with Horizon Chromatique.
ENTRELAC.COOP firmographics
Firmographics- Name
- ENTRELAC.COOP
- Legal name
- ENTRELAC.COOP
- Website
- https://entrelac.coop
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Entrelac.coop is a French cooperative (SCIC) founded in 2022 in Bordeaux that incubates and funds the certification of male contraception medical devices, led by its flagship thermal contraception ring project targeting European pharmacy availability by 2028.
- Ownership category
- akta.pro rank
ENTRELAC.COOP industry classification
Industry- Product category
- Male Contraception Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- akta.pro primary industry
- Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH)
Keywords
Where ENTRELAC.COOP is headquartered
LocationHeadquarters
- HQ city
- Bordeaux
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
ENTRELAC.COOP business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Social Shares (Parts Sociales): Members purchase social shares at 50€ each to become cooperative shareholders and support the company's operations and product development.
- Donations: One-time and recurring donations to support the cooperative's mission, including monthly recurring donations and one-time contributions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Social Share - 50€ per share |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
ENTRELAC.COOP product offering
Product offeringCore offering
Entrelac.coop is a cooperative incubator supporting the development and medical-device certification of a reversible thermal male contraception ring (anneau thermique) that uses heat to provide effective, reversible male contraception comparable to vasectomy. The cooperative also produces and distributes a practical guide to thermal contraception as an educational resource. The product is targeted for European pharmacy availability by 2028.
Product overview
Entrelac.coop is a cooperative company dedicated to innovation in male contraception. Their primary product is the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique), a reversible heat-based male contraceptive device currently undergoing medical device certification with planned availability in European pharmacies by 2028. They also offer a Practical Guide to Thermal Contraception, which serves as an educational resource supporting the ring's use. The cooperative supports project leaders in certification and market launch of male contraception products.
Differentiator
Problem solved
Functional benefit
Products and services
- Anneau de Contraception Masculine Thermique (Thermal Male Contraception Ring) A reversible thermal male contraception ring designed to provide effective male contraception through heat-based technology, targeting effectiveness comparable to vasectomy. Currently under development for medical device certification with planned availability in European pharmacies by 2028. Intended for men seeking reversible contraception alternatives to condoms or female contraceptive methods.
- Guide Pratique de Contraception Thermique (Practical Guide to Thermal Contraception) A free practical guide to thermal male contraception featuring checklists for starting, a bullet journal for daily tracking, a FAQ based on user experience, and a summary of the contraceptive protocol. Distributed as a free downloadable resource supporting use of the thermal ring.
Quantifiable outcome
- Effectiveness comparable to vasectomy or implant according to 3-month spermogram results
- +1 more outcomes
Companies that use ENTRELAC.COOP
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
ENTRELAC.COOP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
ENTRELAC.COOP partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Horizon ChromatiqueminorVisual identity design partner responsible for creating Entrelac.coop's brand visual identity.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
ENTRELAC.COOP competitors and assessment
Company assessmentEmerging players
- Male Contraception Initiative: Non-profit funder of male contraception research that awarded Entrelac its 2022 Development Award. Directly comparable as a stakeholder in the male contraception ecosystem focused on advancing non-hormonal, reversible male contraceptive methods.
- Population Council: International non-profit research organization that has historically led development of contraceptive technologies, including male methods like hormonal gels. Comparable as an R&D-driven reproductive health innovator with mission alignment to Entrelac's equitable contraception focus.
- Callaly: UK-based reproductive health company offering sustainable period care and reproductive health products. Comparable as a European consumer health brand focused on reproductive health innovation with values-aligned positioning.
- Revolution Contraceptives: Medical device startup developing a reversible vas deferens valve for male contraception. Direct peer in the male contraceptive device space with overlapping target market and regulatory pathway.
Direct peers
- Eppin Pharma: US-based biotech developing a non-hormonal, reversible male contraceptive targeting sperm motility via EPPIN protein. Direct peer pursuing a similar goal - reversible, non-hormonal male contraception - with a different mechanism.
- Contraline: US-based medical device company developing a reversible vas deferens occlusion device (Plan A) for male contraception. Direct competitor pursuing the same goal - reversible, non-hormonal male contraception - via a different mechanism.
- NEXT Life Sciences: Developer of Plan A, a reversible vas deferens occlusion device for male contraception. Direct peer competing for the same target market with significant venture backing.
- YourChoice Therapeutics: Biotech company developing a hormonal male contraceptive pill (YCT-529). Direct competitor in the male contraception space with a different technical approach but addressing the same unmet need.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
ENTRELAC.COOP social profiles
Digital presenceENTRELAC.COOP compliance and trust
Trust signalCompliance3 records
ENTRELAC.COOP financial estimates
Financial estimateRevenue estimate
Valuation estimate
ENTRELAC.COOP leadership team
Management profileNumber of profiles
Profiles1 record
ENTRELAC.COOP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ENTRELAC.COOP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ENTRELAC.COOP
What does ENTRELAC.COOP do?
Entrelac.coop is a cooperative incubator supporting the development and medical-device certification of a reversible thermal male contraception ring (anneau thermique) that uses heat to provide effective, reversible male contraception comparable to vasectomy. The cooperative also produces and distributes a practical guide to thermal contraception as an educational resource. The product is targeted for European pharmacy availability by 2028.
Is ENTRELAC.COOP a public or private company?
ENTRELAC.COOP is a private company. It is classified as management employee owned and is currently operating.
When was ENTRELAC.COOP founded?
ENTRELAC.COOP was founded in 2022. It employs 1 to 10 people.
Where is ENTRELAC.COOP based?
ENTRELAC.COOP is headquartered in Bordeaux, France, in the Europe region.
How does ENTRELAC.COOP make money?
Two revenue lines are on record. Social Shares (Parts Sociales) is the primary driver. The others are donations.
Who are ENTRELAC.COOP's main competitors?
Emerging players on record are Male Contraception Initiative, Population Council, Callaly and Revolution Contraceptives. Direct peers are Eppin Pharma, Contraline, NEXT Life Sciences and YourChoice Therapeutics.
Does ENTRELAC.COOP have an API?
No public API is recorded for ENTRELAC.COOP.
What industry is ENTRELAC.COOP in?
ENTRELAC.COOP's product category is Male Contraception Medical Devices. Its primary akta.pro industry code is CRADAMAH, Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests). Its NAICS code is 339113.